Jennifer Buell, President and Chief Executive Officer of MiNK Therapeutics and Executive Council at Agenus, shared a post on X:
“Great Pres by Johanna Joyce AACR25 Prior cancer tx leave fibrotic scars — immune safehouses where dormant tumor cells hide and exhaustion reigns. PV macrophages responding to TGFβ drive. Potential for INKTs AGENT797 to break the cycle and reignite immune attack.”
